Editorial
 A DANGEROUS FDI POLICY   
 Wednesday, June 29, 2016 
 The Centre‚Äôs decision to allow 74 per cent foreign direct investments in brownfield pharmaceutical projects in automatic route will have serious implications in this critical sector and to the people of the country. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]NIH researchers say some women with PCOS may have adrenal disorder
17:00  [IST]Sysmex Inostics opens global OncoBEAM training center in Barcelona
16:55  [IST]RJN Apollo Spectra launches inpatient care unit in Gwalior
16:50  [IST]Bhatia Hospital bags three awards
16:45  [IST]StemRx receives award in Clinical Research category at National Awards for Excellence in Healthcare
16:40  [IST]Eye Q bags Innovation in Quality of service Delivery award
more news >>
TOP NEWS
08:00  [IST]Health ministry issues Revised Draft Guidelines on Similar Biologics
08:00  [IST]Flywheel Logistics chief now sees GST to eliminate C&F agents in pharma sector and boost profitability
08:00  [IST]IIPA urges DCGI sub-committee to set up registry of online pharmacies
08:00  [IST]KMSCL to initiate action against Adroit Pharma for filing of forged documents; DC dept to take legal action
08:00  [IST]MMC writes to state govt to notify elections urgently for its effective administration
08:00  [IST]BIRAC to support cutting edge technologies in areas of medical electronics
more news >>
YESTERDAY'S NEWS
18:00  [IST]Videojet gets INTERPHEX 2016 Exhibitor Award for Best Technology Innovation
17:00  [IST]Health and Human Services calls on CIADM to accelerate Zika vaccine development
16:00  [IST]Icagen buys Sanofi's Oro Valley, Arizona research facility
15:00  [IST]Phonak to introduce next generation rechargeable hearing aid platform Belong
14:00  [IST]Sobi receives Swiss approval for Elocta to treat haemophilia A
13:40  [IST]Amil Pharma eyes Rs. 100 cr revenues by end of FY2017 from herbal diabetic drug BGR-34 developed by CSIR units NBRI and CIMAP
more news >>
INTERVIEW  
Need for responsible waste management by pharma industry to tackle antibiotic resistance
Anurag Roy, Business Unit Director, Asia Pacific, Middle East and Africa, DSM Sinochem Pharmaceuticals Pvt Ltd
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the ban on 344 FDC drugs by the Union Health Ministry came all of a sudden as is being argued by the industry?
 
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |